Pharmacokinetic changes and seizure outcomes in pregnant women taking second-generation antiseizure medications
4 affiliations
- 1Department of Neurology, West China Hospital, West China Xiamen Hospital, Sichuan University, Xiamem, Fujian China
- 2Department of Clinical Pharmacy, West China Hospital, West China Xiamen Hospital, Sichuan University, Xiamen, Fujian China
- 3West China School of Medicine, Sichuan University, Chengdu, Sichuan 610041 China
- 4West China Hospital of Sichuan University, Chengdu, Sichuan 610041 China
Abstract
Background: Effective seizure management in pregnant women with epilepsy poses significant clinical challenges. This study aimed to investigate the pharmacokinetic changes of second-generation antiseizure medications (ASMs) and their association with the deterioration of seizure control in Han Chinese women with epilepsy.
Methods: Patient clinical data including oral daily doses and seizure frequency were acquired from routine clinical practice. Blood concentrations of ASMs determined by therapeutic drug monitoring (TDM) were used to calculate apparent oral clearance (CL) at preconception and each trimester during pregnancy. The ratio of ASM concentration in each trimester to the preconception baseline concentration (RTC) was compared between patients experiencing seizure deterioration and those maintaining stability. Moreover, receiver operating characteristic (ROC) curve analysis was used to identify the threshold RTC value predicting increased seizure frequency.
Results: A total of 52 pregnant patients with epilepsy were initially enrolled in this study. The apparent oral clearance of levetiracetam (LEV) and lamotrigine (LTG) showed a significant increase across all trimesters compared to the nonpregnant baseline. Peak clearance occurred in the third trimester for LTG with a 2.0-fold relative clearance (P < 0.05). Similarly, LEV displayed maximum apparent oral clearance increase during the third trimester, reaching 1.6 folds of baseline value (P < 0.05). As a result, serum concentrations of LEV and LTG significantly decreased during pregnancy compared to non-pregnant baseline levels (P < 0.05). However, the apparent oral clearance and the blood level of oxcarbazepine (OXC) remained stable throughout gestation compared to the preconception baseline. Moreover, the RTC values significantly differed between participants with and without seizure deterioration for all three ASMs, indicating that lower RTCs were associated with seizure worsening.
Conclusions: Our study revealed significant pharmacokinetic fluctuations of LEV and LTG in Chinese pregnant women. This highlights the necessity of early therapeutic drug monitoring for newer ASMs and dose adjustments to maintain blood concentrations near the non-pregnant baseline level in pregnant women with epilepsy.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s42494-026-00275-1.
Related
- Breastfeeding and Neurodevelopmental Outcomes in Children of Women Taking Antiseizure Medications
- Male Reproductive Disorders Associated with Antiseizure Medications: Evidence from Meta-Analysis and FAERS Pharmacovigilance Study
- Modulation of planarian seizure-like activity via antiseizure medications
- CYP2C9 Pharmacogenetic Variants and Adverse Drug Reactions to Antiseizure Medications: An Exploratory Analysis in the Venezuelan Andes.
- Medication Use Patterns and Exposure to High-Risk Medications Among Pregnant Women Seeking Counseling from a Teratology Information Service: A Nine-Year Retrospective Study
BibTeX
@article{hao2026pharmacokinetic,
title = {{Pharmacokinetic changes and seizure outcomes in pregnant women taking second-generation antiseizure medications}},
author = {Nanya Hao and Xiaoli Yi and Renjie Zhao and Xuechen Zhang and Jianxia Dong and Dong Zhou},
journal = {Acta Epileptologica},
year = {2026},
month = oct,
doi = {10.1186/s42494-026-00275-1},
url = {https://doi.org/10.1186/s42494-026-00275-1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Pharmacokinetic changes and seizure outcomes in pregnant women taking second-generation antiseizure medications
AU - Nanya Hao
AU - Xiaoli Yi
AU - Renjie Zhao
AU - Xuechen Zhang
AU - Jianxia Dong
AU - Dong Zhou
PY - 2026
DA - 2026/10/27
JO - Acta Epileptologica
DO - 10.1186/s42494-026-00275-1
UR - https://doi.org/10.1186/s42494-026-00275-1
AB - Background: Effective seizure management in pregnant women with epilepsy poses significant clinical challenges. This study aimed to investigate the pharmacokinetic changes of second-generation antiseizure medications (ASMs) and their association with the deterioration of seizure control in Han Chinese women with epilepsy. Methods: Patient clinical data including oral daily doses and seizure frequency were acquired from routine clinical practice. Blood concentrations of ASMs determined by therapeutic drug monitoring (TDM) were used to calculate apparent oral clearance (CL) at preconception and each trimester during pregnancy. The ratio of ASM concentration in each trimester to the preconception baseline concentration (RTC) was compared between patients experiencing seizure deterioration and those maintaining stability. Moreover, receiver operating characteristic (ROC) curve analysis was used to identify the threshold RTC value predicting increased seizure frequency. Results: A total of 52 pregnant patients with epilepsy were initially enrolled in this study. The apparent oral clearance of levetiracetam (LEV) and lamotrigine (LTG) showed a significant increase across all trimesters compared to the nonpregnant baseline. Peak clearance occurred in the third trimester for LTG with a 2.0-fold relative clearance (P < 0.05). Similarly, LEV displayed maximum apparent oral clearance increase during the third trimester, reaching 1.6 folds of baseline value (P < 0.05). As a result, serum concentrations of LEV and LTG significantly decreased during pregnancy compared to non-pregnant baseline levels (P < 0.05). However, the apparent oral clearance and the blood level of oxcarbazepine (OXC) remained stable throughout gestation compared to the preconception baseline. Moreover, the RTC values significantly differed between participants with and without seizure deterioration for all three ASMs, indicating that lower RTCs were associated with seizure worsening. Conclusions: Our study revealed significant pharmacokinetic fluctuations of LEV and LTG in Chinese pregnant women. This highlights the necessity of early therapeutic drug monitoring for newer ASMs and dose adjustments to maintain blood concentrations near the non-pregnant baseline level in pregnant women with epilepsy. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s42494-026-00275-1.
SN - 2096-9384
SN - 2524-4434
ER -